Fragment-based Drug Discovery Market – Global Industry Size, Trends, Growth, Analysis and Forecast 2018-2026

Global Fragment-based Drug Discovery Market was valued at US$ 503.4 Mn in 2017 expanding at a CAGR of 11.8% from 2018 to 2026

SAN JOSE, United States - December 6, 2018 /MarketersMedia/ —

Fragment-based Drug Discovery Market Expected To Exhibit Rapid Growth During The Forecast Period

The latest market report published by Credence Research, Inc. “Fragment-based Drug Discovery Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026”

Market Insights

There has been a tremendous increase in the drug discovery technologies in the recent past with assistance from functional genomics, combinational chemistry and high-throughput screening. Despite these advancements the number of new chemical entity (NCEs) entering the development phase has remained static. Fragment-based drug discovery has emerged as one of the most productive techniques of lead generation. Fragments are low molecular weight small molecules that form of part of drug molecules.

Browse the full report at

As they binds to an active site of target protein, they can be developed into highly potent and effective drug candidate. Fragment-based drug discovery technique requires less molecules as compared to high-throughput screening while offering more efficient and productive drug candidates. Growing need to curb initially drug discovery cost and time will assist the growth of fragment-based drug discovery market. Moreover, technological advancements in novel drug discovery methods will further boost the market during the forecast period.

In terms of end-users, the fragment-based drug discovery market is led by biopharmaceutical companies. Growing demand of fragment-based method by biopharmaceutical companies is driving the market. Moreover, this technique is also useful where other screening techniques have already failed. In terms of geography, North America held the largest share in the global fragment-based drug discovery market owing to high rate of drug discovery and R&D initiatives undertaken in the region. Moreover, higher acceptance of novel technologies and domicile of major biopharmaceutical giants in the region drive the market.

Asia Pacific is projected to exhibit fastest growth rate during the forecast period owing to rise in outsourcing of pharmaceutical development and growing number of contract research organization (CROs) and contract manufacturing organization (CMOs) in the region. China, India and South Korea are the manufacturing hub worldwide and high investments in the region by pharmaceutical companies further boost the growth of the region, thereby driving the fragment-based drug discovery market in Asia Pacific. The key players operating in the market include Astex Pharmaceuticals, Charles River Laboratories International, Inc., Evotec AG, Kinetic Discovery Limited, and Alveus Pharmaceuticals Pvt. Ltd. among others.

Key Market Movements:

Growing need for cost-effective and time saving drug discovery method
Technological advancement in novel drug discovery techniques
Combination of high-throughput screening and fragment-based drug discovery method for highly efficient lead generation
Growth of CROs and outsourcing of pharmaceutical development in Asia Pacific driving the market


Chapter 4. Global Fragment-based Drug Discovery Market, by Service Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Fragment Screening Technique
4.2.1. NMR Spectroscopy
4.2.2. Differential Scanning Fluorimetry (DSF)
4.2.3. X-Ray Crystallography
4.2.4. Fluorescence Polarization (FP)
4.2.5. Isothermal Titration Calorimetry (ITC)
4.2.6. Surface Plasmon Resonance (SPR)
4.2.7. Mass Spectrometry (MS)
4.2.8. Capillary Electrophoresis (CE)
4.2.9. Others
4.3. Fragment Optimization Technique

Chapter 5. Global Fragment-based Drug Discovery Market, by End-User, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Biopharmaceutical Companies
5.3. Contract Research Organization
5.4. Academic and Research Institutions

Chapter 6. Global Fragment-based Drug Discovery Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America Fragment-based Drug Discovery Market Analysis, 2016 – 2026
6.1.1. North America Fragment-based Drug Discovery Market, by Service Type, 2016 - 2026 (US$ Mn)
6.1.2. North America Fragment-based Drug Discovery Market, by End-User, 2016 - 2026 (US$ Mn)
6.1.3. North America Fragment-based Drug Discovery Market, by Country, 2016 – 2026 (US$ Mn) U.S. Canada
6.2. Europe Fragment-based Drug Discovery Market Analysis, 2016 – 2026
6.2.1. Europe Fragment-based Drug Discovery Market, by Service Type, 2016 - 2026 (US$ Mn)
6.2.2. Europe Fragment-based Drug Discovery Market, by End-User, 2016 - 2026 (US$ Mn)
6.2.3. Europe Fragment-based Drug Discovery Market, by Country/Region, 2016 – 2026 (US$ Mn) ...

Chapter 7. Company Profiles
7.1. Astex Pharmaceuticals
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Alveus Pharmaceuticals Pvt. Ltd.
7.3. Beactica AB
7.4. Charles River Laboratories International, Inc.
7.5. Crown Bioscience, Inc.
7.6. Emerald BioStructures, Inc.
7.7. Evotec AG ...

Browse the full report at

Related Reports :

Osteoarthritis Treatment Market :

Central Nervous System (CNS) Biomarkers Market :

About us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research Inc
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Phone: +18003618290

Source URL:

Source: MarketersMedia

Release ID: 455861

More Press Releases

Get Out! Jordan Peele's 'Us' shatters records with $70.3M

Mar 24, 2019

NEW YORK — Jordan Peele has done it again. Two years after the filmmaker's "Get Out" became a box-office sensation, his frightening follow-up, "Us," debuted with $70.3 million in ticket sales, according to studio estimates Sunday. The opening, well above forecasts, had few parallels. It was the largest debut for an original horror film (only the "It" remake and last year's "Halloween" have surpassed it in the genre) and one of the highest openings for a live-action original film since "Avatar" was released 10 years ago. In today's franchise-driven movie world, seldom has a young director been such a draw....

Chinese leader visits Monaco amid European 5G tech worries

Mar 24, 2019

MONACO — Chinese President Xi Jinping has found one country in Europe that isn't worried about China's growing global clout or its ambitions to dominate the future of technology: Monaco. Xi visited the tiny Mediterranean principality Sunday as part of a European tour that is clouded by mixed feelings about how to engage with China and benefit from its trade — while setting limits on its appetite for greater economic and diplomatic influence. Xi's appearance alongside Monaco's Prince Albert and Princess Charlene marked the first state visit by a Chinese president to the principality. The palace said Monaco is interested...

Dubai denies there were plans for R. Kelly concert

Mar 24, 2019

DUBAI, United Arab Emirates — Dubai's government on Sunday forcefully denied a claim by R&B singer R. Kelly that the artist had planned concerts in the sheikhdom after he had sought permission from an Illinois judge to travel here despite facing sexual-abuse charges. In a rare statement, the government's Dubai Media Office also denied claims by his lawyer in court that Kelly had plans to meet the sheikhdom's ruling Al Maktoum family. "Authorities in Dubai have not received any request for a performance by singer R. Kelly nor are there any venues that have been booked," the statement said. It...

Review: DC superhero pic 'Shazam!' is a joy...seriously

Mar 24, 2019

Holy superhero fatigue, Batman, "Shazam!" is actually good. OK, so it's basically "Big" with superheroes and villains instead of businesspeople and girlfriends, but director David F. Sandberg has infused his film with so much heart and charm that it hardly matters. Even the deficiencies, like the sluggish beginning and the random, ridiculous villains, fade away under a haze of goodwill because unlike so many big spectacle action pics with sequels in mind, "Shazam!" actually sticks the landing. But perhaps I'm getting ahead of myself. Don't worry if you don't happen to know anything about "Shazam!" or are convinced that you...

Adele and Jennifer Lawrence whoop it up at NYC gay bar

Mar 24, 2019

NEW YORK — Bar patrons in New York's Greenwich Village were in the right place at the right time when Adele and Jennifer Lawrence showed up. The Daily News reports Grammy-winning singer Adele and her Oscar-winning actress pal hit the gay bar Pieces on Friday night, to the delight of the crowd. They drank and danced and schmoozed, hugging shirtless men and taking selfies while the crowd applauded. They danced to Kylie Minogue and played a drinking game. And Adele participated in a game show hosted by a drag queen and introduced herself as a married, stay-at-home mom. Adele has...

Broaden News

Reporter Pass is the only access you need to get into Hollywood. No matter it’s the red carpet event or backstage access, we’ve got you covered.

Contact us:

Award ShowsCelebrityPaparazziRoyaltyMoviesMusicTelevision Programs Press Releases